The cytokeratin-positive immunoreactivity in the tumor cells was demonstrated in all the epithelial tumor cases by IHC, and the vimentin-positive immunoreactivity in the tumor cells was also demonstrated in the mesenchymal tumor and melanocytic tumor cases by IHC (Table 1). This evidence concerns the gene VIM and neoplasm.